PYMNTS.com October 16, 2023
Smart regulation is crucial to capturing the potential of future-fit innovations, like artificial intelligence (AI).
The importance of walking a fine line between discovery and safety is increasingly compounded when it comes to sensitive sectors like healthcare where matters of life and death are table stakes.
The U.S. Food and Drug Administration (FDA) announced Wednesday (Oct. 11) that it plans to establish a new Digital Health Advisory Committee to help the agency explore the complex, scientific and technical issues related to digital health technologies (DHTs), such as AI, machine learning (ML), augmented reality (AR), virtual reality (VR), digital therapeutics, wearables, remote patient monitoring and software.
The FDA’s move comes as the healthcare sector joins a list of industries in which...
Today's Sponsors
Today's Sponsor